CD4 and autoimmune thrombocytopenic purpura: Though the mechanisms for this effect were unclear at this moment, we speculate that indirubin might has a therapeutic effect in ITP, at least, partially by promoting the differentiation of CD4+CD25- Treg precursor cells into CD4+CD25+Treg cells.